Group News

Talanx Podcast Insurance Uncovered: Bernd & Bas take stock – No Consent without Consensus.

A strong start to the new financial year. Q1 2024 highlights, outlook for 2024 and what role do equity analysts play in this context?


The new episode of our Talanx Podcast Insurance Uncovered is out now! This month we are going to continue, again in German, our quarterly results series “Bernd & Bas take stock – No Consent without Consensus”. This episode shares insights into our recently published Q1 2024 results, focusing on the net income development and its outlook. Apropos outlook, the reason for the ad hoc announcement released in April, will be explained as well. Which role do equity analysts play in this context and what is the consensus all about. In addition Bernd and Bas will talk about the dividend, which was approved by the Annual General Meeting last week and what the dividend has to do with last week’s drop in the share price. Don't miss this episode and listen right away!

The new episode of our Talanx Podcast Insurance Uncovered with Bernd Sablowsky and Bas de Vries.

Further Information


This news release contains forward-looking statements which are based on certain assumptions, expectations and opinions of the Talanx AG management. These statements are, therefore, subject to certain known or unknown risks and uncertainties. A variety of factors, many of which are beyond Talanx AG’s control, affect Talanx AG’s business activities, business strategy, results, performance and achievements. Should one or more of these factors or risks or uncertainties materialise, actual results, performance or achievements of Talanx AG may vary materially from those expressed or implied in the relevant forward-looking statement. Talanx AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does Talanx AG accept any responsibility for the actual occurrence of the forecasted developments. Talanx AG neither intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.